SEC Company Response from AIM ImmunoTech Inc. (AIM) (CIK 0000946644) (AIM) — Sep 24, 2019
AIM ImmunoTech Inc. (AIM) (CIK 0000946644)
Date: Sept. 24, 2019 · CIK: 0000946644 · Accession: 0001493152-19-014476
AI Filing Summary & Sentiment
File numbers found in text: 333-233657
Show Raw Text
CORRESP
1
filename1.htm
SILVERMAN
SHIN & BYRNE PLLC
Wall
Street Plaza
22nd
Floor
88
Pine Street
NEW
YORK, NY 10005
212.779.8600
Facsimile:
212.779.8858
__________
New
Jersey
19
Engle Street
Tenafly,
NJ 07670
(201)
567-4969
September
23, 2019
VIA
EDGAR
Division
of Corporation Finance
Securities
and Exchange Commission
100
F Street, NE
Washington,
DC 20549
Re:
AIM
ImmunoTech Inc. (the “Company”)
Registration
Statement on Form S-1
(SEC
filing No. 333-233657)
Dear
Sir or Madam:
On
behalf of the Company we file herewith Amendment No. 1 to the above referenced registration statement on Form S-1.
Also
filed herewith please find acceleration requests from the Company and the underwriter requesting that the effective date of the
above-referenced Registration Statement be accelerated so that it will become effective at 5:30 p.m. Eastern Time on September
24, 2019, or as soon thereafter as practicable.
Please
direct any questions or comments to the undersigned, Richard Feiner, Esq., 646 822-1170 (rfeiner@silverfirm.com).
Very
truly yours,
/s/
Richard Feiner
Richard
Feiner
cc: AIM
ImmunoTech Inc.